Corynoline Exhibits Anti-inflammatory Effects in Lipopolysaccharide (LPS)-Stimulated Human Umbilical Vein Endothelial Cells through Activating Nrf2

[1]  G. Zhu,et al.  Corynoline attenuates LPS‐induced acute lung injury in mice by activating Nrf2 , 2017, International immunopharmacology.

[2]  H. Zhang,et al.  Corydalis bungeana Turcz. attenuates LPS-induced inflammatory responses via the suppression of NF-κB signaling pathway in vitro and in vivo. , 2016, Journal of ethnopharmacology.

[3]  H. Kuang,et al.  Corynoline Isolated from Corydalis bungeana Turcz. Exhibits Anti-Inflammatory Effects via Modulation of Nfr2 and MAPKs , 2016, Molecules.

[4]  C. Zazueta,et al.  Nrf2 signaling and redox homeostasis in the aging heart: A potential target to prevent cardiovascular diseases? , 2016, Ageing Research Reviews.

[5]  I. Laher,et al.  Exercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular Diseases , 2015, Oxidative medicine and cellular longevity.

[6]  C. Mozzini,et al.  Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases. , 2015, Free radical biology & medicine.

[7]  W. McNicholas,et al.  Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? , 2009, Thorax.

[8]  J. S. Janicki,et al.  Targeting the Nrf2 pathway against cardiovascular disease , 2009, Expert opinion on therapeutic targets.

[9]  E. Dejana,et al.  The role of junctional adhesion molecules in vascular inflammation , 2007, Nature Reviews Immunology.

[10]  Michael Weis,et al.  Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. , 2005, Clinical science.

[11]  M. Cybulsky,et al.  NF-κB: pivotal mediator or innocent bystander in atherogenesis? , 2001 .

[12]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[13]  F. Hoek,et al.  Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. , 2000, Journal of periodontology.

[14]  A. Griffioen,et al.  Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. , 2000, Pharmacological reviews.

[15]  A. Mantovani,et al.  Cytokine regulation of endothelial cell function: from molecular level to the bedside. , 1997, Immunology today.

[16]  A. Matsumori,et al.  Increased circulating cytokines in patients with myocarditis and cardiomyopathy. , 1994, British heart journal.

[17]  Paul Kubes,et al.  The microcirculation and inflammation: modulation of leukocyte‐endothelial cell adhesion , 1994, Journal of leukocyte biology.

[18]  P. Libby,et al.  An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.

[20]  Julia K Mader,et al.  Adipose tissue, inflammation and cardiovascular disease. , 2010, Revista da Associacao Medica Brasileira.

[21]  D. Giugliano,et al.  Diet and inflammation: a link to metabolic and cardiovascular diseases. , 2006, European heart journal.

[22]  M. Cybulsky,et al.  NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? , 2001, The Journal of clinical investigation.

[23]  Y. Shu.  Recent Natural Products Based Drug Development : A Pharmaceutical Industry Perspective , 1998 .